5029 POSTER Early termination of a phase II study of the Austrian AGO: Weekly docetaxel and irinotecan in platinum-refractory and resistant ovarian cancer

Authors :: C. Marth
M. Deibl
G Bogner
Petra Kohlberger
Birgit Volgger
Alexander Reinthaller
L. Angleitner-Boubenizek
Edgar Petru
G. Wolfram
Source :: European Journal of Cancer Supplements. 5:319
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Phases of clinical research
medicine.disease
Irinotecan
Docetaxel
Platinum resistance
Internal medicine
medicine
business
Ovarian cancer
medicine.drug

Tools